ABBV vs RYAN · P/E 81, rev $61.16B vs P/E 43, rev $2.46B
AbbVie Inc (ABBV) versus Ryan Specialty Group Holdings Inc (RYAN) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Ryan Specialty Group Holdings Inc (RYAN) is a insurance - specialty company listed on NYSE.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported RYAN revenue for 2024-12-31 was $2.46B. Net income was $229.9M. Revenue was up 21.2% from 2023-12-31 to 2024-12-31. RYAN currently screens at market cap $9.33B and trailing P/E 43.1.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. RYAN currently screens at market cap $9.33B and trailing P/E 43.1.
Not investment advice. Open the ABBV and RYAN stock pages for the full models.
Not investment advice.